Barriers to AI Drug Discovery in Japan

FRONTEO, a leading Japanese natural language processing venture, entered the drug discovery service market. But looking at its contents, it fell behind Western biotech ventures. Another problem is that it lacks a mechanism to mass-produce data on its own. Relying on partners is not the way to achieve dominance.
https://miyata-bio.net/column/0000266/